World's Best Scientists 2026 revealed!
John A. Lust

John A. Lust

D-Index & Metrics

Medicine

D-Index
104
Citations
42895
World Ranking
7015
National Ranking
3685

Overview

John A. Lust is affiliated with the Mayo Clinic in the United States and is an active researcher focusing on Medicine, particularly in areas relating to Biochemistry, Genetics, and Molecular Biology. Their work spans a significant number of publications, emphasizing multiple facets of hematologic diseases and molecular mechanisms.

The scientist's expertise covers several main fields and subfields, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Molecular Biology
  • Hematology
  • Oncology
  • Genetics
  • Nephrology

John A. Lust's research topics focus on:

  • Multiple Myeloma Research and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Protein Degradation and Inhibitors
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Parathyroid Disorders and Treatments
  • Glycosylation and Glycoproteins Research

Their recent published papers include:

  • Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response, 2020, Blood Cancer Journal
  • Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities, 2020, Blood Advances
  • Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update, 2021, Mayo Clinic Proceedings
  • Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma, 2020, Clinical Cancer Research
  • MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients, 2021, Blood Cancer Journal

Frequent co-authors working with John A. Lust include:

  • Angela Dispenzieri
  • Taxiarchis Kourelis
  • Morie A. Gertz
  • Shaji Kumar
  • S. Vincent Rajkumar

Publication venues where John A. Lust has frequently contributed are:

  • Blood
  • Blood Cancer Journal
  • Blood Advances
  • American Journal of Hematology
  • Mayo Clinic Proceedings

Best Publications

  • Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • POEMS syndrome: definitions and long-term outcome.

    Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar

  • A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine

    Robert A. Kyle;Morie A. Gertz;Philip R. Greipp;Thomas E. Witzig

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

    S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri

  • Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

    S. Vincent Rajkumar;Suzanne Hayman;Morie A. Gertz;Angela Dispenzieri

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

    John A. Lust;Kathleen A. Donovan;Michael P. Kline;Philip R. Greipp

  • Genomic abnormalities in monoclonal gammopathy of undetermined significance

    Rafael Fonseca;Richard J. Bailey;Gregory J. Ahmann;S. Vincent Rajkumar

  • Clinical course of patients with relapsed multiple myeloma.

    Shaji K. Kumar;Terry M. Therneau;Morie A. Gertz;Martha Q. Lacy

  • Plasma cell labeling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma

    PR Greipp;JA Lust;WM O'Fallon;JA Katzmann

  • Prognostic Value of Bone Marrow Angiogenesis in Multiple Myeloma

    S V Rajkumar;T Leong;P C Roche;R Fonseca

  • Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

    Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri

  • Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • Screening panels for detection of monoclonal gammopathies.

    Jerry A. Katzmann;Robert A. Kyle;Joanne Benson;Dirk R. Larson

  • Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?

    Madhav V. Dhodapkar;Chin Yang Li;John A. Lust;Ayalew Tefferi

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As medical careers continue to evolve, many students are exploring online degrees to broaden their expertise and improve career flexibility. There are now a variety of accredited programs available for those who want to make an impact in healthcare—without attending traditional, on-campus classes.

For those interested in healthcare leadership, pursuing one of the cheapest online mha programs can provide critical management skills at an affordable cost. Meanwhile, nurses aiming for the highest level of clinical practice can look into the cheapest dnp online programs.

Pharmacists seeking advanced credentials may benefit from researching the best online pharmacy school options that fit their budget and career goals. Additionally, health informatics professionals are in high demand; you can accelerate your expertise by choosing an online mhi degree for specialized training in managing healthcare data.

Exploring these online degrees allows you to find flexible, affordable pathways that align with your ambitions and can complement your journey toward a medical career in the USA.

Best Scientists Citing John A. Lust

Trending Scientists

Recently Published Articles